Javier J. Rodriguez's most recent trade in DaVita Inc was a trade of 39,407 Common Stock done at an average price of $209.3 . Disclosure was reported to the exchange on June 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| DaVita | Javier J. Rodriguez | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 209.28 per share. | 15 Jun 2026 | 39,407 | 840,408 (0%) | 0% | 209.3 | 8,247,018 | Common Stock |
| DaVita | Javier J. Rodriguez | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 209.50 per share. | 15 Jun 2026 | 30,000 | 879,815 (0%) | 0% | 209.5 | 6,285,090 | Common Stock |
| Gilead Sciences | Javier J. Rodriguez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2026 | 4,884 | 4,884 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Gilead Sciences | Javier J. Rodriguez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2026 | 1,146 | 13,364 (0%) | 0% | 0 | Common Stock | |
| DaVita | Javier J. Rodriguez | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2026 | 56,506 | 56,506 | - | - | Stock Appreciation Rights | |
| DaVita | Javier J. Rodriguez | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2026 | 20,900 | 909,815 (0%) | 0% | 0 | Common Stock | |
| DaVita | Javier J. Rodriguez | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.55 per share. | 15 Nov 2025 | 5,165 | 888,915 (0%) | 0% | 121.6 | 627,806 | Common Stock |
| Gilead Sciences | Javier J. Rodriguez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2025 | 6,809 | 6,809 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Gilead Sciences | Javier J. Rodriguez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2025 | 1,516 | 12,218 (0%) | 0% | 0 | Common Stock | |
| DaVita | Javier J. Rodriguez | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2025 | 52,106 | 52,106 | - | - | Stock Appreciation Rights | |
| DaVita | Javier J. Rodriguez | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2025 | 18,822 | 894,080 (0%) | 0% | 0 | Common Stock | |
| DaVita | Javier J. Rodriguez | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2024 | 37,423 | 875,258 (0%) | 0% | 0 | Common Stock | |
| DaVita | Javier J. Rodriguez | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 165.05 per share. | 13 Sep 2024 | 50,000 | 837,835 (0%) | 0% | 165.1 | 8,252,515 | Common Stock |
| DaVita | Javier J. Rodriguez | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 162.85 per share. | 13 Sep 2024 | 9,881 | 887,835 (0%) | 0% | 162.9 | 1,609,122 | Common Stock |
| DaVita | Javier J. Rodriguez | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 155.93 per share. | 26 Aug 2024 | 32,176 | 905,659 (0%) | 0% | 155.9 | 5,017,303 | Common Stock |
| DaVita | Javier J. Rodriguez | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 155.93 per share. | 26 Aug 2024 | 7,943 | 897,716 (0%) | 0% | 155.9 | 1,238,589 | Common Stock |
| DaVita | Javier J. Rodriguez | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 67.80 per share. | 20 Aug 2024 | 750,000 | 1,453,929 (1%) | 0% | 67.8 | 50,850,000 | Common Stock |
| DaVita | Javier J. Rodriguez | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Aug 2024 | 750,000 | 0 | - | - | Stock Appreciation Rights | |
| DaVita | Javier J. Rodriguez | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 152.17 per share. | 20 Aug 2024 | 334,166 | 1,119,763 (0%) | 0% | 152.2 | 50,850,040 | Common Stock |
| DaVita | Javier J. Rodriguez | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 152.17 per share. | 20 Aug 2024 | 181,928 | 937,835 (0%) | 0% | 152.2 | 27,683,984 | Common Stock |
| Gilead Sciences | Javier J. Rodriguez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 12,648 | 12,648 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Gilead Sciences | Javier J. Rodriguez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 2,310 | 10,702 (0%) | 0% | 0 | Common Stock | |
| DaVita | Javier J. Rodriguez | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 67.80 per share. | 06 Mar 2024 | 750,000 | 1,244,480 (0%) | 0% | 67.8 | 50,850,000 | Common Stock |
| DaVita | Javier J. Rodriguez | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2024 | 750,000 | 750,000 | - | - | Stock Appreciation Rights | |
| DaVita | Javier J. Rodriguez | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 134.65 per share. | 06 Mar 2024 | 377,646 | 866,834 (0%) | 0% | 134.7 | 50,850,034 | Common Stock |
| DaVita | Javier J. Rodriguez | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 134.65 per share. | 06 Mar 2024 | 162,905 | 703,929 (0%) | 0% | 134.6 | 21,935,158 | Common Stock |
| DaVita | J. Javier Rodriguez | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2024 | 450,000 | 1,550,000 | - | - | Stock Appreciation Rights | |
| DaVita | Rodriguez Javier J. | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 67.80 per share. | 26 Feb 2024 | 450,000 | 889,002 (0%) | 0% | 67.8 | 30,510,000 | Common Stock |
| DaVita | Javier Rodriguez J. | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 125.26 per share. | 26 Feb 2024 | 243,574 | 645,428 (0%) | 0% | 125.3 | 30,510,079 | Common Stock |
| DaVita | Javier Rodriguez J. | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 125.26 per share. | 26 Feb 2024 | 89,128 | 556,300 (0%) | 0% | 125.3 | 11,164,173 | Common Stock |
| DaVita | Rodriguez J. Javier | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 126.11 per share. | 26 Feb 2024 | 67,603 | 488,697 (0%) | 0% | 126.1 | 8,525,130 | Common Stock |
| DaVita | Javier Rodriguez J. | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 67.80 per share. | 26 Feb 2024 | 50,000 | 531,300 (0%) | 0% | 67.8 | 3,390,000 | Common Stock |
| DaVita | Javier Rodriguez J. | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2024 | 50,000 | 1,500,000 | - | - | Stock Appreciation Rights | |
| DaVita | Rodriguez J. Javier | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 127.60 per share. | 26 Feb 2024 | 26,568 | 504,732 (0%) | 0% | 127.6 | 3,390,077 | Common Stock |
| DaVita | Javier Rodriguez J. | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 127.60 per share. | 26 Feb 2024 | 10,252 | 494,480 (0%) | 0% | 127.6 | 1,308,155 | Common Stock |
| DaVita | J. Rodriguez Javier | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 126.87 per share. | 26 Feb 2024 | 7,397 | 481,300 (0%) | 0% | 126.9 | 938,467 | Common Stock |
| DaVita | Javier Rodriguez J. | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2023 | 500,000 | 2,000,000 | - | - | Stock Appreciation Rights | |
| DaVita | J. Javier Rodriguez | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 67.80 per share. | 14 Dec 2023 | 500,000 | 833,299 (0%) | 0% | 67.8 | 33,900,000 | Common Stock |
| DaVita | Javier Rodriguez J. | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 108.80 per share. | 14 Dec 2023 | 311,581 | 521,718 (0%) | 0% | 108.8 | 33,900,013 | Common Stock |
| DaVita | Rodriguez J. Javier | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 108.80 per share. | 14 Dec 2023 | 82,716 | 439,002 (0%) | 0% | 108.8 | 8,999,501 | Common Stock |
| DaVita | Javier J. Rodriguez | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 96.86 per share. | 15 May 2023 | 25,805 | 333,299 (0%) | 0% | 96.9 | 2,499,472 | Common Stock |
| DaVita | Javier J. Rodriguez | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 96.86 per share. | 15 May 2023 | 15,298 | 359,104 (0%) | 0% | 96.9 | 1,481,764 | Common Stock |
| Gilead Sciences | Javier J. Rodriguez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 10,173 | 10,173 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Gilead Sciences | Javier J. Rodriguez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 1,887 | 8,392 (0%) | 0% | 0 | Common Stock | |
| DaVita | Javier J. Rodriguez | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2022 | 79,909 | 0 | - | - | Stock Appreciation Rights | |
| DaVita | Javier J. Rodriguez | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 65.48 per share. | 06 Jun 2022 | 79,909 | 381,059 (0%) | 0% | 65.5 | 5,232,441 | Common Stock |
| DaVita | Javier J. Rodriguez | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 96.70 per share. | 06 Jun 2022 | 54,111 | 326,948 (0%) | 0% | 96.7 | 5,232,534 | Common Stock |
| DaVita | Javier J. Rodriguez | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 96.70 per share. | 06 Jun 2022 | 11,326 | 315,622 (0%) | 0% | 96.7 | 1,095,224 | Common Stock |
| DaVita | Javier J. Rodriguez | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.05 per share. | 12 May 2022 | 29,076 | 320,321 (0%) | 0% | 100.1 | 2,909,054 | Common Stock |
| DaVita | Javier J. Rodriguez | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2022 | 24,890 | 379,311 (0%) | 0% | 0 | Common Stock | |
| DaVita | Javier J. Rodriguez | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.05 per share. | 12 May 2022 | 17,233 | 362,078 (0%) | 0% | 100.1 | 1,724,162 | Common Stock |
| DaVita | Javier J. Rodriguez | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.05 per share. | 12 May 2022 | 15,298 | 301,150 (0%) | 0% | 100.1 | 1,530,565 | Common Stock |
| DaVita | Javier J. Rodriguez | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.05 per share. | 12 May 2022 | 12,681 | 349,397 (0%) | 0% | 100.0 | 1,268,734 | Common Stock |
| DaVita | Javier J. Rodriguez | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.05 per share. | 12 May 2022 | 3,873 | 316,448 (0%) | 0% | 100.1 | 387,494 | Common Stock |
| Gilead Sciences | Javier J. Rodriguez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 15,851 | 15,851 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Gilead Sciences | Javier J. Rodriguez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 2,444 | 6,505 (0%) | 0% | 0 | Common Stock | |
| Gilead Sciences | Javier J. Rodriguez | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2022 | 2,223 | 4,061 (0%) | 0% | - | Common Stock | |
| Gilead Sciences | Javier J. Rodriguez | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2022 | 2,223 | 0 | - | - | Restricted Stock Unit | |
| DaVita | Javier J. Rodriguez | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Apr 2022 | 66,230 | 340,057 (0%) | 0% | 0 | Common Stock | |
| DaVita | Javier J. Rodriguez | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Apr 2022 | 28,884 | 273,827 (0%) | 0% | 0 | Common Stock | |
| DaVita | Javier J. Rodriguez | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Apr 2022 | 14,364 | 354,421 (0%) | 0% | 0 | Common Stock |